Search research articles
Contact Us
Filters
Showing results (21-30 of 81) with videos related to
Page
of 9
Sort By:
Blood
|
May 2, 2015
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug
Martin Wermke, Aylin Camgoz, Maciej Paszkowski-Rogacz, et al.
The Lancet. Oncology
|
September 11, 2025
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study
Kelly G Paulson, Sally C M Lau, Myung-Ju Ahn, et al.
Cancer Discovery
|
September 4, 2025
Histologic Transformation in Cancer: The Path for Clinical Translation
Ioannis Vathiotis, Avisek Banerjee, Utsav Sen, et al.
Journal for Immunotherapy of Cancer
|
October 24, 2018
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Christophe Le Tourneau, Christopher Hoimes, Corrine Zarwan, et al.
Annals of Hematology
|
August 12, 2016
Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q
Ekaterina Balaian, Claudia Schuster, Claudia Schönefeldt, et al.
International Journal of Molecular Sciences
|
February 10, 2024
In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of Cryopreservation
Genqiao Jiang, Brigitte Neuber, Angela Hückelhoven-Krauss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2012
MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation
Martin Wermke, Anne Schmidt, Jan Moritz Middeke, et al.
Stem Cells (Dayton, Ohio)
|
September 30, 2015
Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome
Felix von Dalowski, Michael Kramer, Martin Wermke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 29, 2014
Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis
Philippe Armand, Haesook T Kim, Johanna M Virtanen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 25, 2018
Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Jan M Middeke, Frederike Kollinger, Henning Baldauf, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 81) with videos related to
Sort By:
Page
of 9
Blood
|
May 2, 2015
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug
Martin Wermke, Aylin Camgoz, Maciej Paszkowski-Rogacz, et al.
The Lancet. Oncology
|
September 11, 2025
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study
Kelly G Paulson, Sally C M Lau, Myung-Ju Ahn, et al.
Cancer Discovery
|
September 4, 2025
Histologic Transformation in Cancer: The Path for Clinical Translation
Ioannis Vathiotis, Avisek Banerjee, Utsav Sen, et al.
Journal for Immunotherapy of Cancer
|
October 24, 2018
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Christophe Le Tourneau, Christopher Hoimes, Corrine Zarwan, et al.
Annals of Hematology
|
August 12, 2016
Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q
Ekaterina Balaian, Claudia Schuster, Claudia Schönefeldt, et al.
International Journal of Molecular Sciences
|
February 10, 2024
In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of Cryopreservation
Genqiao Jiang, Brigitte Neuber, Angela Hückelhoven-Krauss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2012
MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation
Martin Wermke, Anne Schmidt, Jan Moritz Middeke, et al.
Stem Cells (Dayton, Ohio)
|
September 30, 2015
Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome
Felix von Dalowski, Michael Kramer, Martin Wermke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 29, 2014
Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis
Philippe Armand, Haesook T Kim, Johanna M Virtanen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 25, 2018
Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Jan M Middeke, Frederike Kollinger, Henning Baldauf, et al.
Page
of 9